| [1] | Gassiep I, Armstrong M, Norton R. Human melioidosis. Clin Microbiol Rev 2020;33(2):e00006 − 19. https://doi.org/10.1128/CMR.00006-19. |
| [2] | Norman FF, Chen LH. Travel-associated melioidosis: a narrative review. J Travel Med 2023;30(3):taad039. https://doi.org/10.1093/jtm/taad039. |
| [3] | Zheng X, Xia QF, Xia LX, Li W. Endemic melioidosis in Southern China: past and present. Trop Med Infect Dis 2019;4(1):39. https://doi.org/10.3390/tropicalmed4010039. |
| [4] | Chewapreecha C, Holden MTG, Vehkala M, Välimäki N, Yang ZR, Harris SR, et al. Global and regional dissemination and evolution ofBurkholderia pseudomallei. Nat Microbiol 2017;2(4):16263. https://doi.org/10.1038/nmicrobiol.2016.263. |
| [5] | Limmathurotsakul D, Jamsen K, Arayawichanont A, Simpson JA, White LJ, Lee SJ, et al. Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One 2010;5(8):e12485. https://doi.org/10.1371/journal.pone.0012485. |
| [6] | Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010;4(11):e900. https://doi.org/10.1371/journal.pntd.0000900. |
| [7] | Limmathurotsakul D, Golding N, Dance DAB, Messina JP, Pigott DM, Moyes CL, et al. Predicted global distribution ofBurkholderia pseudomalleiand burden of melioidosis. Nat Microbiol 2016;1(1):15008. https://doi.org/10.1038/nmicrobiol.2015.8. |